NASDAQ:CTRECaretrust REIT Stock Price, Forecast & News

Caretrust REIT's stock was trading at $16.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CTRE stock has increased by 16.5% and is now trading at $19.79. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Caretrust REIT in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Caretrust REIT.

Caretrust REIT is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Caretrust REIT.

Caretrust REIT Inc (NASDAQ:CTRE) announced its quarterly earnings results on Thursday, May, 7th. The real estate investment trust reported $0.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by $0.14. The real estate investment trust had revenue of $44.34 million for the quarter, compared to analyst estimates of $43.20 million. Caretrust REIT had a return on equity of 5.32% and a net margin of 29.53%. View Caretrust REIT's earnings history.

Caretrust REIT announced a quarterly dividend on Friday, March 13th. Investors of record on Tuesday, March 31st will be given a dividend of $0.25 per share on Wednesday, April 15th. This represents a $1.00 annualized dividend and a dividend yield of 5.05%. The ex-dividend date is Monday, March 30th. This is a boost from Caretrust REIT's previous quarterly dividend of $0.23. View Caretrust REIT's dividend history.

Caretrust REIT issued an update on its FY 2020 After-Hours earnings guidance on Thursday, May, 7th. The company provided earnings per share guidance of 1.32-1.34 for the period.

7 analysts have issued 1-year price objectives for Caretrust REIT's stock. Their forecasts range from $13.00 to $26.00. On average, they expect Caretrust REIT's stock price to reach $21.29 in the next year. This suggests a possible upside of 7.6% from the stock's current price. View analysts' price targets for Caretrust REIT.

Media stories about CTRE stock have trended neutral on Saturday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Caretrust REIT earned a coverage optimism score of 0.4 on InfoTrie's scale. They also assigned media stories about the real estate investment trust a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the immediate future. View the latest news aboutCaretrust REIT.

Caretrust REIT saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 1,790,000 shares, a decrease of 15.6% from the April 30th total of 2,120,000 shares. Based on an average daily volume of 999,900 shares, the short-interest ratio is presently 1.8 days. Currently, 1.9% of the shares of the company are sold short. View Caretrust REIT's Current Options Chain.

Some companies that are related to Caretrust REIT include AGNC Investment (AGNC), Omega Healthcare Investors (OHI), Kilroy Realty (KRC), Lamar Advertising (LAMR), Federal Realty Investment Trust (FRT), Klepierre (KLPEF), AmeriCold Realty Trust (COLD), Vereit (VER), National Retail Properties (NNN), Kimco Realty (KIM), Apartment Investment and Management (AIV), Healthcare Trust Of America (HTA), Store Capital (STOR), Douglas Emmett (DEI) and CubeSmart (CUBE). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Caretrust REIT investors own include Omega Healthcare Investors (OHI), AGNC Investment (AGNC), Energy Transfer LP Unit (ET), Cisco Systems (CSCO), Medical Properties Trust (MPW), NVIDIA (NVDA), AT&T (T), Verizon Communications (VZ), Enterprise Products Partners (EPD) and Exxon Mobil (XOM).

Caretrust REIT trades on the NASDAQ under the ticker symbol "CTRE."

Caretrust REIT's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (18.94%), PGGM Investments (9.32%), State Street Corp (4.37%), Invesco Ltd. (3.96%), Bank of New York Mellon Corp (3.19%) and Geode Capital Management LLC (1.50%). View institutional ownership trends for Caretrust REIT.

CTRE stock was sold by a variety of institutional investors in the last quarter, including Centersquare Investment Management LLC, Morgan Stanley, Morgan Stanley, BlackRock Inc., Bank of New York Mellon Corp, Baird Financial Group Inc., Victory Capital Management Inc., and Victory Capital Management Inc.. View insider buying and selling activity for Caretrust REIT.

CTRE stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Cohen & Steers Inc., State Street Corp, Employees Retirement System of Texas, Invesco Ltd., Two Sigma Advisers LP, Nuveen Asset Management LLC, and Geode Capital Management LLC. View insider buying and selling activity for Caretrust REIT.

Shares of CTRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CTRE stock can currently be purchased for approximately $19.79.

Caretrust REIT has a market capitalization of $1.89 billion and generates $163.40 million in revenue each year. The real estate investment trust earns $46.36 million in net income (profit) each year or $1.36 on an earnings per share basis. Caretrust REIT employs 57 workers across the globe.

The official website for Caretrust REIT is www.caretrustreit.com.

Caretrust REIT's mailing address is 905 CALLE AMANECER SUITE 300, SAN CLEMENTE CA, 92673. The real estate investment trust can be reached via phone at 949-542-3130 or via email at [email protected]